<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mediators Inflamm</journal-id><journal-id journal-id-type="iso-abbrev">Mediators Inflamm</journal-id><journal-id journal-id-type="publisher-id">MI</journal-id><journal-title-group><journal-title>Mediators of Inflammation</journal-title></journal-title-group><issn pub-type="ppub">0962-9351</issn><issn pub-type="epub">1466-1861</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4739260</article-id><article-id pub-id-type="doi">10.1155/2016/7852168</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Manipulation of P2X Receptor Activities by Light Stimulation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Sang Seong</given-names></name><xref ref-type="aff" rid="I1"/><xref ref-type="corresp" rid="cor1"><sup>*</sup>
</xref></contrib></contrib-group><aff id="I1">Department of Pharmacy, Hanyang University, ERICA Campus, 55 Hanyangdaehak-ro, Sangnok-gu, Ansan, Gyeonggi-do 426-791, Republic of Korea</aff><author-notes><corresp id="cor1">*Sang Seong Kim: <email>talpiot@hanyang.ac.kr</email></corresp><fn fn-type="other"><p>Academic Editor: Mauricio Retamal</p></fn></author-notes><pub-date pub-type="ppub"><year>2016</year></pub-date><pub-date pub-type="epub"><day>17</day><month>1</month><year>2016</year></pub-date><volume>2016</volume><elocation-id>7852168</elocation-id><history><date date-type="received"><day>30</day><month>10</month><year>2015</year></date><date date-type="rev-recd"><day>16</day><month>12</month><year>2015</year></date><date date-type="accepted"><day>22</day><month>12</month><year>2015</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2016 Sang Seong Kim.</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>P2X receptors are involved in amplification of inflammatory responses in peripheral nociceptive fibers and in mediating pain-related signals to the CNS. Control of P2X activation has significant importance in managing unwanted hypersensitive neuron responses. To overcome the limitations of chemical ligand treatment, optical stimulation methods of optogenetics and photoswitching achieve efficient control of P2X activation while allowing specificity at the target site and convenient stimulation by light illumination. There are many potential applications for photosensitive elements, such as improved uncaging methods, photoisomerizable ligands, photoswitches, and gold nanoparticles. Each technique has both advantages and downsides, and techniques are selected according to the purpose of the application. Technical advances not only provide novel approaches to manage inflammation or pain mediated by P2X receptors but also suggest a similar approach for controlling other ion channels.</p></abstract></article-meta></front><body><sec id="sec1"><title>1. Introduction</title><p>P2X receptors belong to the ATP-gated cation channel family, which has seven members [<xref rid="B1" ref-type="bibr">1</xref>&#x02013;<xref rid="B8" ref-type="bibr">8</xref>]. The receptor structure consists of trimeric homo- or heteromers with two transmembrane domains (TM1 and TM2) [<xref rid="B2" ref-type="bibr">2</xref>&#x02013;<xref rid="B4" ref-type="bibr">4</xref>]. P2X receptors have various roles in neuropathic pain [<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B6" ref-type="bibr">6</xref>], synaptic transmission [<xref rid="B2" ref-type="bibr">2</xref>], cancer [<xref rid="B7" ref-type="bibr">7</xref>], neurodegenerative disorders [<xref rid="B8" ref-type="bibr">8</xref>], and inflammation [<xref rid="B9" ref-type="bibr">9</xref>&#x02013;<xref rid="B12" ref-type="bibr">12</xref>]. Release of ATP during inflammation is characteristic at the site of injury. Activated inflammatory cells release a plethora of ATP extracellularly in an uncontrolled fashion from intracellular storage [<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B14" ref-type="bibr">14</xref>]. In some cases, controlled release of ATP is observed through transmembrane proteins connexin or pannexin [<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B15" ref-type="bibr">15</xref>]. ATP also functions as a neurotransmitter in primary afferent neurons by relaying pain information to the CNS [<xref rid="B16" ref-type="bibr">16</xref>]. Considering the distribution of P2X, its involvement in nociceptive sensation cannot be ruled out. P2X1 to P2X6 are expressed in sensory ganglia, especially in dorsal root ganglia (DRG) [<xref rid="B17" ref-type="bibr">17</xref>]. The dense expression of P2X3 in small diameter DRG and its coexpression with TRPV1 implicate P2X3 as a designated pain sensor [<xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B19" ref-type="bibr">19</xref>]. Thus, activation of P2X in inflammatory or noxious conditions provokes widespread responses in neuropathic pain. Nerve damage induces upregulation of P2X receptors, leading to hypersensitivity [<xref rid="B20" ref-type="bibr">20</xref>].</p><p>Considering the fundamental contribution of P2X receptors in pain and inflammation, receptor modulation has therapeutic significance. Traditionally, chemical compounds are applied to local tissues or systemic circulation to control ion channel activity. Oral intake, stable structure in ordinary conditions, and high efficacy at target sites are advantages of using chemical drugs. However, side effects resulting from systemic distribution and harmful metabolite production require improved approaches. Due to advances in the optogenetic field in the last decade, novel techniques have been introduced to control ion channel activity. The use of photoswitches or genetically modified receptors has increased specificity in controlling target channel activities with optimal light stimulation. In addition to optogenetics, the incorporation of novel materials into cells has enabled optimal control of intact receptors without genetic modifications. These techniques encompass important target channels or receptors involved in neuronal firing, inflammation, or incurable diseases. P2X receptors are targets of interest due to their important role in inflammation and nociceptive sensation. This review investigates past trials on control of P2X receptors by light stimulation and explores cutting edge techniques with potential for therapeutic application.</p></sec><sec id="sec2"><title>2. Activation of P2X Receptors by Releasing ATP from Photosensitive Caging Compounds</title><p>In conventional neuronal stimulation, an electric stimulus is delivered through an electric probe to activate the group of neurons surrounding the probe. This direct electrical activation is easily applicable with a potential caveat of nonspecific activation of neuronal circuits. P2X receptors have been favored for optical stimulation due to their simple channel architecture, large extracellular ligand binding domain, and relatively rare presence in the CNS [<xref rid="B21" ref-type="bibr">21</xref>&#x02013;<xref rid="B24" ref-type="bibr">24</xref>]. The initial application was with an uncaging method that tethered ATP to caging compounds as a protecting group. The first generation was 2-nitrobenzyl (NB) esters of ATP that were susceptible to photolysis by UV light [<xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B26" ref-type="bibr">26</xref>]. The side effect of NB photolysis, however, produced reactive by-product compounds that interfered with reliable interpretation of the response. Improved second-generation caging groups, such as 4,5-dimethoxy-2-nitrobenzyl (DMNB) and <italic>&#x003b1;</italic>-carboxy-2-nitrobenzyl (CNB), overcame these limitations with fewer by-products and stable kinetics [<xref rid="B27" ref-type="bibr">27</xref>]. Indeed, robust neuronal spikes were generated in P2X2 expressing neurons using a 1&#x02009;s UV light pulse (355&#x02009;nm) in the presence of DMNPE-ATP [<xref rid="B28" ref-type="bibr">28</xref>]. P2X2 activation kinetics fell into the millisecond range in a reproducible manner, suggesting applications in spatially restricted sites to invoke the intended neuronal activation. This scenario was realized in phototrigger experiments affecting the locomotor behavior of flies. Lima and Miesenb&#x000f6;ck expressed P2X2 in a small group of neurons of the giant fiber (GF) system through DMNPE-ATP injection in the CNS [<xref rid="B29" ref-type="bibr">29</xref>]. Brief UV illumination for 150&#x02013;250&#x02009;ms provoked characteristic escape movements mediated through giant fibers without desensitization in repeated photostimulation of 2.5&#x02009;s intervals. The induction of dopaminergic signaling by photostimulation of P2X2 expressing dopaminergic neurons increased locomotor activities affecting the walking pattern of flies. Likewise, remote control of P2X activation by photostimulation not only changed the cellular response but also caused behavioral changes.</p></sec><sec id="sec3"><title>3. Control of Neuronal Activation by Photoisomerizable Molecules Transporting through P2X Receptor Pores</title><p>The optochemical genetic approach has downsides in therapeutic applications due to exogenous expression of effective receptors and systemic injection of caging compounds, which generates nonselective cellular responses. To circumvent these problems, photoisomerizable molecules were introduced through certain receptor pores. They then underwent conformational changes induced by light stimulation. This idea was originally developed to silence nociceptive neurons by delivering membrane-impermeable local anesthetic lidocaine, QX-314, intracellularly with the help of TRPV1 pore opening [<xref rid="B30" ref-type="bibr">30</xref>]. The attempt was successful in allowing QX-314 influx by TRPV1 activation, but structural irreversibility of the compound lasted for several hours, preventing therapeutic usage [<xref rid="B31" ref-type="bibr">31</xref>].</p><p>To overcome this limitation, Mourot et al. developed a novel photoswitch, quaternary ammonium-azobenzene-quaternary ammonium (QAQ). QAQ has versatile isomerizable characteristics and converts from the elongated<italic> trans</italic>&#x02009;&#x02009;form to bent<italic> cis </italic>form with 380&#x02009;nm light [<xref rid="B32" ref-type="bibr">32</xref>]. Once introduced intracellularly, the<italic> trans</italic> form of QAQ blocks various voltage-gated Na<sup>+</sup>, Ca<sup>2+</sup>, and K<sup>+</sup> channels with the few exceptions of inward-rectifier (Kir), hyperpolarization-activated cyclic nucleotide-gated (HCN) channels,<italic> N</italic>-methyl-D-aspartic acid (NMDA), and non-NMDA receptors. Light stimulation of 380&#x02009;nm on QAQ embedded neurons recovered the silenced nociceptive neurons, restoring their firing rate and action potential amplitude. Light of 500&#x02009;nm generated the opposite effect. The transition with light of specific wavelengths was evoked in an on and off fashion without altering basic neuronal properties such as resting membrane potential or firing threshold. QAQ can enter cells through large ionic pores, which limits the number of mediator channels or receptors. TRPV1 expressing cells showed sufficient QAQ loading in the presence of capsaicin [<xref rid="B32" ref-type="bibr">32</xref>]. P2X7 also proved its eligibility for photosensitization with ATP treatment [<xref rid="B32" ref-type="bibr">32</xref>, <xref rid="B33" ref-type="bibr">33</xref>]. In heterologous expression of HEK 293 cells, P2X7 demonstrated photosensitization of Shaker K<sup>+</sup> channels by QAQ application in the presence of ATP. Endogenous voltage-gated K<sup>+</sup> channel activity was also prone to photocontrol through exogenously expressed P2X7 receptors in cultured rat hippocampal neurons.</p><p>This novel photoswitching technology is applicable in pain and inflammation control due to the immense role of TRPV1 and P2X7 in pathological processes. Because QAQ has selective entry without affecting nonnociceptive neurons, it provides an effective peripheral analgesic method. QAQ can enter any nociceptor location from the cell soma to the long axonal process and nerve endings through pores of mediating channels, which is impossible with conventional electrophysiology or drugs.</p></sec><sec id="sec4"><title>4. Optogating of P2X Receptors through Introduction of Photoswitches into the Subunits </title><p>With recent advances in optogenetic technology, remote control of neuronal activity enables selective activation of certain neuronal circuits, leading to local or systemic changes on demand. Among various applications, pharmacology takes advantage of photoswitchable ligands, which are tethered to genetically modified receptor sites. Photoisomerizable chemical ligands can convert geographical structures into more favorable forms by light stimulation with a specific wavelength, enabling binding to active sites of receptors. This method improved conventional chemical stimulation by increasing the specificity of target locations and instant stimulation.</p><p>Efforts have been made to enable optogating of P2X receptors. An azobenzene ammonium derivative was synthesized to create a maleimide ethylene azobenzene trimethyl ammonium derivative (MEA-TMA). This was photoisomerized from the long<italic> trans</italic>-isomer to the<italic> cis</italic>-isomer by applying a 365&#x02009;nm light, a change that was reversed with 525&#x02009;nm light [<xref rid="B34" ref-type="bibr">34</xref>]. MEA-TMA was affixed to a modified P2X receptor, P2X2-3T, in which outer transmembrane residues were substituted to cysteine [<xref rid="B35" ref-type="bibr">35</xref>]. Indeed, 365&#x02009;nm light precisely opened the channel within a short temporal range, reaching maximal current in almost 1 second. The optogating of P2X2 consisted of two different mechanisms, an ATP dependent pore-blocking pathway and direct binding to the receptor without ATP. With ATP independent opening, a pore dilation effect was still observed with<italic> N</italic>-methyl-D-glucamine (NMDG) treatment [<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B36" ref-type="bibr">36</xref>, <xref rid="B37" ref-type="bibr">37</xref>].</p><p>A similar attempt using azobenzene isomerization was made for optical control of p2X2 and P2X3 receptors. In this experiment,<italic> bis</italic>(maleimido)azobenzene (BMA) was synthesized to bridge receptor subunits of TM2 through covalent linkage to cysteine residues [<xref rid="B38" ref-type="bibr">38</xref>]. BMA underwent conformational changes between the<italic> cis</italic> and<italic> trans </italic>forms at 360 and 440&#x02009;nm illumination, respectively. P2X2 receptor P329C mutation with BMA treatment allowed an inward current with 440&#x02009;nm in the absence of ATP. Cysteine substitution of P320C at an equivalent site of P2X3 also generated light-activated current, as with P2X2 activation. Homomeric expression of each channel and P2X2/3 heteromeric expression showed rapid photocontrol with opening at 440&#x02009;nm and closing at 360&#x02009;nm in HEK293 cells and PC12 cells. Photoisomerization showed similar receptor kinetics as ATP activation. This result suggests that gating rearrangement is the limiting factor of P2X activation, not agonist-binding steps.</p></sec><sec id="sec5"><title>5. Neuronal Activation Using Gold Particles to Target Intact P2X Receptors</title><p>Various methods have been suggested to achieve specific optical stimulation of neurons, as described above. P2X receptor activation photoswitch or photoisomerization offers custom designed activation tools. However, genetic modification of receptors is inevitable. Actual application in nongenetically modified animals, including humans, is hindered. To overcome this limitation, direct optical stimulation of intact neurons is proposed by applying infrared (IR) wavelength to neuronal membranes [<xref rid="B39" ref-type="bibr">39</xref>, <xref rid="B40" ref-type="bibr">40</xref>]. IR wavelength delivers energy in the form of heat to cellular membranes, leading to upregulation of membrane capacitance. This elevated membrane capacitance results in depolarization and action potential generation.</p><p>To effectively deliver heat to cell membranes, gold nanorods (AuNRs) or spherical gold nanoparticles (AuNPs) are treated in cell culture media to absorb IR energy and convert it to heat. In this way, cultured neurons can evoke cellular activation by IR or near-infrared (NIR) excitation [<xref rid="B41" ref-type="bibr">41</xref>&#x02013;<xref rid="B43" ref-type="bibr">43</xref>]. Bezanilla et al. elaborated upon this method by using channel specific antibodies and second antibodies conjugated with AuNPs to specifically activate neurons expressing target channels [<xref rid="B44" ref-type="bibr">44</xref>]. They initially tested dorsal root ganglion (DRG) neurons with Ts1-conjugated AuNPs. Light of 532&#x02009;nm was sufficient to generate action potentials in DRG neurons, even with repetitive washout and multiple photostimulations. The next trial targeted endogenously expressed channels such as TRPV1 and P2X3. Overnight incubation of DRG neurons with each antibody following AuNP-secondary antibody treatment demonstrated the photosensitivity of DRG neurons to green light stimulation (532&#x02009;nm). The amplitude of action potentials generated by light stimulation was almost equal to that of electrical stimulation. Long washout time of more than 20&#x02009;min still preserved responsiveness to light, proving tight binding of primary antibodies. This method encourages clinical applications to control nociceptive neuronal activation in pain or inflammation. Unlike any other technique, this method does not require injection of a virus containing modified receptor DNA at the site of interest. Instead, simple treatment with AuNP-conjugated antibody and NIR illumination is sufficient to activate target neurons. Since the activation mechanism does not depend on temperature itself but rather on the rate of temperature change, less intense light stimulation can be applied to avoid tissue damage.</p></sec><sec id="sec6"><title>6. Conclusion</title><p>Growth in optogenetics has generated abundant opsin containing channels with ample wavelength ranges of light stimulation to activate or deactivate neurons. Channelrhodopsins and halorhodopsins are the most representative light-gated ion channels, and each intracellularly introduces cations and anions. Genetic expression of these photosensitive channels using viral vectors is helpful for controlling neuronal activities. However, introduction of foreign genes can cause derangements in proper protein expression. Therefore, receptors already present in nerves are safer targets. P2X receptors are choice candidates for light stimulation because they are functionally expressed in the periphery and CNS to govern inflammatory and nociceptive pathways. For a long time, uncaging of ATP by UV light has been the primary method used to activate P2X receptors. Improved caging compounds are now used to reduce by-products. The isomerizable property of azobenzene introduced a new way to construct photoswitches that can reversibly change conformations. Photoswitches can be incorporated into receptor subunits or used as light sensitive ligands. Controlling both receptors and ligands by light stimulation enables many options for combinatorial manipulation of neuronal activation. Even intact receptors can receive light stimulation. The novel concept of applying gold particles to convert light energy into heat proved the possibility of activating neurons by increasing membrane conductance. Using specific antibodies for pain receptors such as P2X, gold nanoparticles target intact receptors to activate nerves.</p><p>Although there are diverse benefits with light stimulation techniques, every method inevitably introduces limitations also. Our goal is to improve current methods to increase specificity while developing safer applications in humans. The fields of optics and material science suggest innovative technical advances for new ideas.</p></sec></body><back><ack><title>Acknowledgments</title><p>This work is supported by funding from the Ministry of Science, ICT, and Future Planning of Korea (NRF-2013R1A1A1012884) and Hanyang University (201200000002393) to Sang Seong Kim.</p></ack><sec sec-type="conflict"><title>Conflict of Interests</title><p>The author declares that there is no conflict of interests regarding the publication of this paper.</p></sec><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burnstock</surname><given-names>G.</given-names></name><name><surname>Wong</surname><given-names>H.</given-names></name></person-group><article-title>Comparison of the effects of ultraviolet light and purinergic nerve stimulation on the guinea-pig taenia coli</article-title><source><italic>British Journal of Pharmacology</italic></source><year>1978</year><volume>62</volume><issue>2</issue><fpage>293</fpage><lpage>302</lpage><pub-id pub-id-type="doi">10.1111/j.1476-5381.1978.tb08459.x</pub-id><pub-id pub-id-type="other">2-s2.0-0017839786</pub-id><pub-id pub-id-type="pmid">623941</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khakh</surname><given-names>B. S.</given-names></name><name><surname>North</surname><given-names>R. A.</given-names></name></person-group><article-title>Neuromodulation by extracellular ATP and P2X Receptors in the CNS</article-title><source><italic>Neuron</italic></source><year>2012</year><volume>76</volume><issue>1</issue><fpage>51</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2012.09.024</pub-id><pub-id pub-id-type="other">2-s2.0-84867132775</pub-id><pub-id pub-id-type="pmid">23040806</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coddou</surname><given-names>C.</given-names></name><name><surname>Yan</surname><given-names>Z.</given-names></name><name><surname>Obsil</surname><given-names>T.</given-names></name><name><surname>Pablo Huidobro-Toro</surname><given-names>J.</given-names></name><name><surname>Stojilkovic</surname><given-names>S. S.</given-names></name></person-group><article-title>Activation and regulation of purinergic P2X receptor channels</article-title><source><italic>Pharmacological Reviews</italic></source><year>2011</year><volume>63</volume><issue>3</issue><fpage>641</fpage><lpage>683</lpage><pub-id pub-id-type="doi">10.1124/pr.110.003129</pub-id><pub-id pub-id-type="other">2-s2.0-79955950645</pub-id><pub-id pub-id-type="pmid">21737531</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaczmarek-H&#x000e1;jek</surname><given-names>K.</given-names></name><name><surname>L&#x000f6;rinczi</surname><given-names>&#x000c9;.</given-names></name><name><surname>Hausmann</surname><given-names>R.</given-names></name><name><surname>Nicke</surname><given-names>A.</given-names></name></person-group><article-title>Molecular and functional properties of P2X receptors&#x02014;recent progress and persisting challenges</article-title><source><italic>Purinergic Signalling</italic></source><year>2012</year><volume>8</volume><issue>3</issue><fpage>375</fpage><lpage>417</lpage><pub-id pub-id-type="doi">10.1007/s11302-012-9314-7</pub-id><pub-id pub-id-type="other">2-s2.0-84861526394</pub-id><pub-id pub-id-type="pmid">22547202</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beggs</surname><given-names>S.</given-names></name><name><surname>Trang</surname><given-names>T.</given-names></name><name><surname>Salter</surname><given-names>M. W.</given-names></name></person-group><article-title>P2X4R<sup>+</sup> microglia drive neuropathic pain</article-title><source><italic>Nature Neuroscience</italic></source><year>2012</year><volume>15</volume><issue>8</issue><fpage>1068</fpage><lpage>1073</lpage><pub-id pub-id-type="doi">10.1038/nn.3155</pub-id><pub-id pub-id-type="other">2-s2.0-84864487226</pub-id><pub-id pub-id-type="pmid">22837036</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chizh</surname><given-names>B. A.</given-names></name><name><surname>Illes</surname><given-names>P.</given-names></name></person-group><article-title>P2X receptors and nociception</article-title><source><italic>Pharmacological Reviews</italic></source><year>2001</year><volume>53</volume><issue>4</issue><fpage>553</fpage><lpage>568</lpage><pub-id pub-id-type="other">2-s2.0-0035211065</pub-id><pub-id pub-id-type="pmid">11734618</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>N.</given-names></name><name><surname>Burnstock</surname><given-names>G.</given-names></name></person-group><article-title>P2 receptors and cancer</article-title><source><italic>Trends in Pharmacological Sciences</italic></source><year>2006</year><volume>27</volume><issue>4</issue><fpage>211</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1016/j.tips.2006.02.004</pub-id><pub-id pub-id-type="other">2-s2.0-33645977207</pub-id><pub-id pub-id-type="pmid">16530853</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burnstock</surname><given-names>G.</given-names></name></person-group><article-title>Purinergic signalling: its unpopular beginning, its acceptance and its exciting future</article-title><source><italic>BioEssays</italic></source><year>2012</year><volume>34</volume><issue>3</issue><fpage>218</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.1002/bies.201100130</pub-id><pub-id pub-id-type="other">2-s2.0-84857045446</pub-id><pub-id pub-id-type="pmid">22237698</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Virgilio</surname><given-names>F.</given-names></name></person-group><article-title>Liaisons dangereuses: P2X<sub>7</sub> and the inflammasome</article-title><source><italic>Trends in Pharmacological Sciences</italic></source><year>2007</year><volume>28</volume><issue>9</issue><fpage>465</fpage><lpage>472</lpage><pub-id pub-id-type="doi">10.1016/j.tips.2007.07.002</pub-id><pub-id pub-id-type="other">2-s2.0-34548444551</pub-id><pub-id pub-id-type="pmid">17692395</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Virgilio</surname><given-names>F.</given-names></name></person-group><article-title>P2X receptors and inflammation</article-title><source><italic>Current Medicinal Chemistry</italic></source><year>2015</year><volume>22</volume><issue>7</issue><fpage>866</fpage><lpage>877</lpage><pub-id pub-id-type="doi">10.2174/0929867322666141210155311</pub-id><pub-id pub-id-type="pmid">25524252</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beamer</surname><given-names>E.</given-names></name><name><surname>G&#x000f6;l&#x000f6;ncs&#x000e9;r</surname><given-names>F.</given-names></name><name><surname>Horv&#x000e1;th</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Purinergic mechanisms in neuroinflammation: an update from molecules to behavior</article-title><source><italic>Neuropharmacology</italic></source><year>2015</year><pub-id pub-id-type="doi">10.1016/j.neuropharm.2015.09.019</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Idzko</surname><given-names>M.</given-names></name><name><surname>Ferrari</surname><given-names>D.</given-names></name><name><surname>Eltzschig</surname><given-names>H. K.</given-names></name></person-group><article-title>Nucleotide signalling during inflammation</article-title><source><italic>Nature</italic></source><year>2014</year><volume>509</volume><issue>7500</issue><fpage>310</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.1038/nature13085</pub-id><pub-id pub-id-type="other">2-s2.0-84900530332</pub-id><pub-id pub-id-type="pmid">24828189</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Junger</surname><given-names>W. G.</given-names></name></person-group><article-title>Immune cell regulation by autocrine purinergic signalling</article-title><source><italic>Nature Reviews Immunology</italic></source><year>2011</year><volume>11</volume><issue>3</issue><fpage>201</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.1038/nri2938</pub-id><pub-id pub-id-type="other">2-s2.0-79952192382</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eltzschig</surname><given-names>H. K.</given-names></name><name><surname>Sitkovsky</surname><given-names>M. V.</given-names></name><name><surname>Robson</surname><given-names>S. C.</given-names></name></person-group><article-title>Purinergic signaling during inflammation</article-title><source><italic>The New England Journal of Medicine</italic></source><year>2012</year><volume>367</volume><issue>24</issue><fpage>2322</fpage><lpage>2333</lpage><pub-id pub-id-type="doi">10.1056/nejmra1205750</pub-id><pub-id pub-id-type="other">2-s2.0-84871048026</pub-id><pub-id pub-id-type="pmid">23234515</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eltzschig</surname><given-names>H. K.</given-names></name><name><surname>Eckle</surname><given-names>T.</given-names></name><name><surname>Mager</surname><given-names>A.</given-names></name><etal/></person-group><article-title>ATP release from activated neutrophils occurs via connexin 43 and modulates adenosine-dependent endothelial cell function</article-title><source><italic>Circulation Research</italic></source><year>2006</year><volume>99</volume><issue>10</issue><fpage>1100</fpage><lpage>1108</lpage><pub-id pub-id-type="doi">10.1161/01.res.0000250174.31269.70</pub-id><pub-id pub-id-type="other">2-s2.0-33750929739</pub-id><pub-id pub-id-type="pmid">17038639</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poelchen</surname><given-names>W.</given-names></name><name><surname>Sieler</surname><given-names>D.</given-names></name><name><surname>Wirkner</surname><given-names>K.</given-names></name><name><surname>Illes</surname><given-names>P.</given-names></name></person-group><article-title>Co-transmitter function of ATP in central catecholaminergic neurons of the rat</article-title><source><italic>Neuroscience</italic></source><year>2001</year><volume>102</volume><issue>3</issue><fpage>593</fpage><lpage>602</lpage><pub-id pub-id-type="doi">10.1016/S0306-4522(00)00529-7</pub-id><pub-id pub-id-type="other">2-s2.0-0035808833</pub-id><pub-id pub-id-type="pmid">11226696</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norenberg</surname><given-names>W.</given-names></name><name><surname>Illes</surname><given-names>P.</given-names></name></person-group><article-title>Neuronal P2X receptors: localisation and functional properties</article-title><source><italic>Naunyn-Schmiedeberg's Archives of Pharmacology</italic></source><year>2000</year><volume>362</volume><issue>4-5</issue><fpage>324</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.1007/s002100000311</pub-id><pub-id pub-id-type="other">2-s2.0-0033755889</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiang</surname><given-names>Z.</given-names></name><name><surname>Bo</surname><given-names>X.</given-names></name><name><surname>Burnstock</surname><given-names>G.</given-names></name></person-group><article-title>Localization of ATP-gated P2X receptor immunoreactivity in rat sensory and sympathetic ganglia</article-title><source><italic>Neuroscience Letters</italic></source><year>1998</year><volume>256</volume><issue>2</issue><fpage>105</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1016/s0304-3940(98)00774-5</pub-id><pub-id pub-id-type="other">2-s2.0-0032491542</pub-id><pub-id pub-id-type="pmid">9853714</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>A.</given-names></name><name><surname>Vulchanova</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Elde</surname><given-names>R.</given-names></name></person-group><article-title>Immunocytochemical localization of the vanilloid receptor 1 (VR1): relationship to neuropeptides, the P2X<sub>3</sub> purinoceptor and IB4 binding sites</article-title><source><italic>European Journal of Neuroscience</italic></source><year>1999</year><volume>11</volume><issue>3</issue><fpage>946</fpage><lpage>958</lpage><pub-id pub-id-type="doi">10.1046/j.1460-9568.1999.00503.x</pub-id><pub-id pub-id-type="pmid">10103088</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fabbretti</surname><given-names>E.</given-names></name><name><surname>D'Arco</surname><given-names>M.</given-names></name><name><surname>Fabbro</surname><given-names>A.</given-names></name><name><surname>Simonetti</surname><given-names>M.</given-names></name><name><surname>Nistri</surname><given-names>A.</given-names></name><name><surname>Giniatullin</surname><given-names>R.</given-names></name></person-group><article-title>Delayed upregulation of ATP P2X3 receptors of trigeminal sensory neurons by calcitonin gene-related peptide</article-title><source><italic>Journal of Neuroscience</italic></source><year>2006</year><volume>26</volume><issue>23</issue><fpage>6163</fpage><lpage>6171</lpage><pub-id pub-id-type="doi">10.1523/jneurosci.0647-06.2006</pub-id><pub-id pub-id-type="other">2-s2.0-33745623434</pub-id><pub-id pub-id-type="pmid">16763024</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fountain</surname><given-names>S. J.</given-names></name><name><surname>Burnstock</surname><given-names>G.</given-names></name></person-group><article-title>An evolutionary history of P2X receptors</article-title><source><italic>Purinergic Signalling</italic></source><year>2009</year><volume>5</volume><issue>3</issue><fpage>269</fpage><lpage>272</lpage><pub-id pub-id-type="doi">10.1007/s11302-008-9127-x</pub-id><pub-id pub-id-type="other">2-s2.0-68349152690</pub-id><pub-id pub-id-type="pmid">19015952</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chataigneau</surname><given-names>T.</given-names></name><name><surname>Lemoine</surname><given-names>D.</given-names></name><name><surname>Grutter</surname><given-names>T.</given-names></name></person-group><article-title>Exploring the ATP-binding site of P2X receptors</article-title><source><italic>Frontiers in Cellular Neuroscience</italic></source><year>2013</year><volume>7, article 273</volume><pub-id pub-id-type="doi">10.3389/fncel.2013.00273</pub-id><pub-id pub-id-type="other">2-s2.0-84892186102</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>R. J.</given-names></name></person-group><article-title>Structural interpretation of P2X receptor mutagenesis studies on drug action</article-title><source><italic>British Journal of Pharmacology</italic></source><year>2010</year><volume>161</volume><issue>5</issue><fpage>961</fpage><lpage>971</lpage><pub-id pub-id-type="doi">10.1111/j.1476-5381.2010.00728.x</pub-id><pub-id pub-id-type="other">2-s2.0-77958610109</pub-id><pub-id pub-id-type="pmid">20977449</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rettinger</surname><given-names>J.</given-names></name><name><surname>Schmalzing</surname><given-names>G.</given-names></name></person-group><article-title>Activation and desensitization of the recombinant P2X1 receptor at nanomolar ATP concentrations</article-title><source><italic>Journal of General Physiology</italic></source><year>2003</year><volume>121</volume><issue>5</issue><fpage>451</fpage><lpage>461</lpage><pub-id pub-id-type="doi">10.1085/jgp.200208730</pub-id><pub-id pub-id-type="other">2-s2.0-0037625979</pub-id><pub-id pub-id-type="pmid">12719485</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCray</surname><given-names>J. A.</given-names></name><name><surname>Herbette</surname><given-names>L.</given-names></name><name><surname>Kihara</surname><given-names>T.</given-names></name><name><surname>Trentham</surname><given-names>D. R.</given-names></name></person-group><article-title>A new approach to time-resolved studies of ATP-requiring biological systems; laser flash photolysis of caged ATP</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>1980</year><volume>77</volume><issue>12</issue><fpage>7237</fpage><lpage>7241</lpage><pub-id pub-id-type="pmid">6938971</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaplan</surname><given-names>J. H.</given-names></name><name><surname>Forbush</surname><given-names>B.</given-names><suffix>III</suffix></name><name><surname>Hoffman</surname><given-names>J. F.</given-names></name></person-group><article-title>Rapid photolytic release of adenosine 5&#x02032;-triphosphate from a protected analogue: Utilization by the Na:K pump of human red blood cell ghosts</article-title><source><italic>Biochemistry</italic></source><year>1978</year><volume>17</volume><issue>10</issue><fpage>1929</fpage><lpage>1935</lpage><pub-id pub-id-type="doi">10.1021/bi00603a020</pub-id><pub-id pub-id-type="other">2-s2.0-0017867017</pub-id><pub-id pub-id-type="pmid">148906</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amatrudo</surname><given-names>J. M.</given-names></name><name><surname>Olson</surname><given-names>J. P.</given-names></name><name><surname>Agarwal</surname><given-names>H. K.</given-names></name><name><surname>Ellis-Davies</surname><given-names>G. C. R.</given-names></name></person-group><article-title>Caged compounds for multichromic optical interrogation of neural systems</article-title><source><italic>European Journal of Neuroscience</italic></source><year>2015</year><volume>41</volume><issue>1</issue><fpage>5</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1111/ejn.12785</pub-id><pub-id pub-id-type="other">2-s2.0-84919665692</pub-id><pub-id pub-id-type="pmid">25471355</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zemelman</surname><given-names>B. V.</given-names></name><name><surname>Nesnas</surname><given-names>N.</given-names></name><name><surname>Lee</surname><given-names>G. A.</given-names></name><name><surname>Miesenb&#x000f6;ck</surname><given-names>G.</given-names></name></person-group><article-title>Photochemical gating of heterologous ion channels: remote control over genetically designated populations of neurons</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>2003</year><volume>100</volume><issue>3</issue><fpage>1352</fpage><lpage>1357</lpage><pub-id pub-id-type="doi">10.1073/pnas.242738899</pub-id><pub-id pub-id-type="other">2-s2.0-0037417982</pub-id><pub-id pub-id-type="pmid">12540832</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lima</surname><given-names>S. Q.</given-names></name><name><surname>Miesenb&#x000f6;ck</surname><given-names>G.</given-names></name></person-group><article-title>Remote control of behavior through genetically targeted photostimulation of neurons</article-title><source><italic>Cell</italic></source><year>2005</year><volume>121</volume><issue>1</issue><fpage>141</fpage><lpage>152</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2005.02.004</pub-id><pub-id pub-id-type="other">2-s2.0-17044431846</pub-id><pub-id pub-id-type="pmid">15820685</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Binshtok</surname><given-names>A. M.</given-names></name><name><surname>Bean</surname><given-names>B. P.</given-names></name><name><surname>Woolf</surname><given-names>C. J.</given-names></name></person-group><article-title>Inhibition of nociceptors by TRPV1-mediated entry of impermeant sodium channel blockers</article-title><source><italic>Nature</italic></source><year>2007</year><volume>449</volume><issue>7162</issue><fpage>607</fpage><lpage>610</lpage><pub-id pub-id-type="doi">10.1038/nature06191</pub-id><pub-id pub-id-type="other">2-s2.0-34948819283</pub-id><pub-id pub-id-type="pmid">17914397</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Binshtok</surname><given-names>A. M.</given-names></name><name><surname>Gerner</surname><given-names>P.</given-names></name><name><surname>Oh</surname><given-names>S. B.</given-names></name><etal/></person-group><article-title>Coapplication of lidocaine and the permanently charged sodium channel blocker QX-314 produces a long-lasting nociceptive blockade in rodents</article-title><source><italic>Anesthesiology</italic></source><year>2009</year><volume>111</volume><issue>1</issue><fpage>127</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.1097/aln.0b013e3181a915e7</pub-id><pub-id pub-id-type="other">2-s2.0-67650067619</pub-id><pub-id pub-id-type="pmid">19512868</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mourot</surname><given-names>A.</given-names></name><name><surname>Fehrentz</surname><given-names>T.</given-names></name><name><surname>Le Feuvre</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Rapid optical control of nociception with an ion-channel photoswitch</article-title><source><italic>Nature Methods</italic></source><year>2012</year><volume>9</volume><issue>4</issue><fpage>396</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1897</pub-id><pub-id pub-id-type="other">2-s2.0-84862794890</pub-id><pub-id pub-id-type="pmid">22343342</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Browne</surname><given-names>L. E.</given-names></name><name><surname>Compan</surname><given-names>V.</given-names></name><name><surname>Bragg</surname><given-names>L.</given-names></name><name><surname>North</surname><given-names>R. A.</given-names></name></person-group><article-title>P2X7 receptor channels allow direct permeation of nanometer-sized dyes</article-title><source><italic>The Journal of Neuroscience</italic></source><year>2013</year><volume>33</volume><issue>8</issue><fpage>3557</fpage><lpage>3566</lpage><pub-id pub-id-type="doi">10.1523/jneurosci.2235-12.2013</pub-id><pub-id pub-id-type="other">2-s2.0-84874195644</pub-id><pub-id pub-id-type="pmid">23426683</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lemoine</surname><given-names>D.</given-names></name><name><surname>Habermacher</surname><given-names>C.</given-names></name><name><surname>Martz</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Optical control of an ion channel gate</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>2013</year><volume>110</volume><issue>51</issue><fpage>20813</fpage><lpage>20818</lpage><pub-id pub-id-type="doi">10.1073/pnas.1318715110</pub-id><pub-id pub-id-type="other">2-s2.0-84890834989</pub-id><pub-id pub-id-type="pmid">24297890</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Chang</surname><given-names>T.-H.</given-names></name><name><surname>Silberberg</surname><given-names>S. D.</given-names></name><name><surname>Swartz</surname><given-names>K. J.</given-names></name></person-group><article-title>Gating the pore of P2X receptor channels</article-title><source><italic>Nature Neuroscience</italic></source><year>2008</year><volume>11</volume><issue>8</issue><fpage>883</fpage><lpage>887</lpage><pub-id pub-id-type="doi">10.1038/nn.2151</pub-id><pub-id pub-id-type="other">2-s2.0-48149111510</pub-id><pub-id pub-id-type="pmid">18587390</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khakh</surname><given-names>B. S.</given-names></name><name><surname>Bao</surname><given-names>X. R.</given-names></name><name><surname>Labarca</surname><given-names>C.</given-names></name><name><surname>Lester</surname><given-names>H. A.</given-names></name></person-group><article-title>Neuronal P2X transmitter-gated cation channels change their ion selectivity in seconds</article-title><source><italic>Nature Neuroscience</italic></source><year>1999</year><volume>2</volume><issue>4</issue><fpage>322</fpage><lpage>330</lpage><pub-id pub-id-type="doi">10.1038/7233</pub-id><pub-id pub-id-type="other">2-s2.0-0033366463</pub-id><pub-id pub-id-type="pmid">10204538</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Virginio</surname><given-names>C.</given-names></name><name><surname>MacKenzie</surname><given-names>A.</given-names></name><name><surname>Rassendren</surname><given-names>F. A.</given-names></name><name><surname>North</surname><given-names>R. A.</given-names></name><name><surname>Surprenant</surname><given-names>A.</given-names></name></person-group><article-title>Pore dilation of neuronal P2X receptor channels</article-title><source><italic>Nature Neuroscience</italic></source><year>1999</year><volume>2</volume><issue>4</issue><fpage>315</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.1038/7225</pub-id><pub-id pub-id-type="other">2-s2.0-0033360313</pub-id><pub-id pub-id-type="pmid">10204537</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Browne</surname><given-names>L. E.</given-names></name><name><surname>Nunes</surname><given-names>J. P.</given-names></name><name><surname>Sim</surname><given-names>J. A.</given-names></name><etal/></person-group><article-title>Optical control of trimeric P2X receptors and acid-sensing ion channels</article-title><source><italic>Proceedings of the National Academy of Sciences</italic></source><year>2014</year><volume>111</volume><issue>1</issue><fpage>521</fpage><lpage>526</lpage><pub-id pub-id-type="doi">10.1073/pnas.1318582111</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wells</surname><given-names>J.</given-names></name><name><surname>Kao</surname><given-names>C.</given-names></name><name><surname>Mariappan</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Optical stimulation of neural tissue <italic>in vivo</italic></article-title><source><italic>Optics Letters</italic></source><year>2005</year><volume>30</volume><issue>5</issue><fpage>504</fpage><lpage>506</lpage><pub-id pub-id-type="doi">10.1364/ol.30.000504</pub-id><pub-id pub-id-type="pmid">15789717</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shapiro</surname><given-names>M. G.</given-names></name><name><surname>Homma</surname><given-names>K.</given-names></name><name><surname>Villarreal</surname><given-names>S.</given-names></name><name><surname>Richter</surname><given-names>C.-P.</given-names></name><name><surname>Bezanilla</surname><given-names>F.</given-names></name></person-group><article-title>Infrared light excites cells by changing their electrical capacitance</article-title><source><italic>Nature Communications</italic></source><year>2012</year><volume>3, article 736</volume><pub-id pub-id-type="doi">10.1038/ncomms1742</pub-id><pub-id pub-id-type="other">2-s2.0-84859188313</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eom</surname><given-names>K.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Choi</surname><given-names>J. M.</given-names></name><etal/></person-group><article-title>Enhanced infrared neural stimulation using localized surface plasmon resonance of gold nanorods</article-title><source><italic>Small</italic></source><year>2014</year><volume>10</volume><issue>19</issue><fpage>3853</fpage><lpage>3857</lpage><pub-id pub-id-type="doi">10.1002/smll.201400599</pub-id><pub-id pub-id-type="other">2-s2.0-84908478936</pub-id><pub-id pub-id-type="pmid">24975778</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yong</surname><given-names>J.</given-names></name><name><surname>Needham</surname><given-names>K.</given-names></name><name><surname>Brown</surname><given-names>W. G.</given-names></name><etal/></person-group><article-title>Gold-nanorod-assisted near-infrared stimulation of primary auditory neurons</article-title><source><italic>Advanced Healthcare Materials</italic></source><year>2014</year><volume>3</volume><issue>11</issue><fpage>1862</fpage><lpage>1868</lpage><pub-id pub-id-type="doi">10.1002/adhm.201400027</pub-id><pub-id pub-id-type="pmid">24799427</pub-id></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roper</surname><given-names>D. K.</given-names></name><name><surname>Ahn</surname><given-names>W.</given-names></name><name><surname>Hoepfner</surname><given-names>M.</given-names></name></person-group><article-title>Microscale heat transfer transduced by surface plasmon resonant gold nanoparticles</article-title><source><italic>The Journal of Physical Chemistry C</italic></source><year>2007</year><volume>111</volume><issue>9</issue><fpage>3636</fpage><lpage>3641</lpage><pub-id pub-id-type="doi">10.1021/jp064341w</pub-id><pub-id pub-id-type="other">2-s2.0-33947423256</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carvalho-de-Souza</surname><given-names>J. L.</given-names></name><name><surname>Treger</surname><given-names>J. S.</given-names></name><name><surname>Dang</surname><given-names>B.</given-names></name><name><surname>Kent</surname><given-names>S. B. H.</given-names></name><name><surname>Pepperberg</surname><given-names>D. R.</given-names></name><name><surname>Bezanilla</surname><given-names>F.</given-names></name></person-group><article-title>Photosensitivity of neurons enabled by cell-targeted gold nanoparticles</article-title><source><italic>Neuron</italic></source><year>2015</year><volume>86</volume><issue>1</issue><fpage>207</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2015.02.033</pub-id><pub-id pub-id-type="pmid">25772189</pub-id></element-citation></ref></ref-list></back></article>